Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Single dose aztreonam in treating gonorrhoea.

I B Tait, J Winning, J D Sleigh

    Genitourinary Medicine
    |February 1, 1987
    PubMed
    Summary

    Aztreonam effectively cured urogenital gonorrhea in 100% of patients. However, treatment failures occurred in rectal and pharyngeal sites, despite no observed in vitro resistance to this antibiotic.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Coronavirus disease 2019 (COVID-19): update for anesthesiologists and intensivists March 2020.

    Der Anaesthesist·2020
    Same author

    [Coronavirus disease 2019 (COVID-19): update for anesthesiologists and intensivists March 2020].

    Der Anaesthesist·2020
    Same author

    [In order to see clearly it is often sufficient just to change the perspective].

    Der Unfallchirurg·2016
    Same author

    [Critical incidents in preclinical emergency airway management : Evaluation of the CIRS emergency medicine databank].

    Der Anaesthesist·2013
    Same author

    Beneficial effect of clopidogrel in a mouse model of polymicrobial sepsis.

    Journal of thrombosis and haemostasis : JTH·2009
    Same author

    Molecular biology on the ICU. From understanding to treating sepsis.

    Minerva anestesiologica·2006

    Area of Science:

    • Infectious Diseases
    • Microbiology
    • Pharmacology

    Background:

    • Gonorrhea remains a significant public health concern globally.
    • Antimicrobial resistance in Neisseria gonorrhoeae necessitates the evaluation of alternative treatment options.
    • Aztreonam is a monobactam antibiotic with activity against Gram-negative bacteria.

    Purpose of the Study:

    • To evaluate the efficacy and safety of a single intramuscular dose of aztreonam for treating urogenital gonorrhea.
    • To assess treatment outcomes at different anatomical sites, including rectal and pharyngeal infections.

    Main Methods:

    • A prospective study involving 108 consecutive patients diagnosed with urogenital gonorrhea.
    • Treatment administered as a single 1g intramuscular dose of aztreonam.
    • Clinical and microbiological evaluation of 102 patients post-treatment.

    Main Results:

    • A 100% cure rate was achieved at urogenital sites.
    • Treatment failure was observed in 3 out of 14 (21%) patients with rectal or pharyngeal gonorrhea.
    • No instances of in vitro aztreonam resistance were detected among the evaluated isolates.

    Conclusions:

    • Single intramuscular dose of aztreonam demonstrates high efficacy for urogenital gonorrhea.
    • Efficacy may be reduced for non-urogenital sites like the rectum and pharynx.
    • Further investigation is warranted for aztreonam's role in treating resistant gonorrhea strains.

    Related Experiment Videos